TT&A advised Sanofi Healthcare India Private Limited (SHIPL) and Hoechst GmbH (Hoechst) in relation to an inter-se transfer of the equity share capital of Sanofi India Limited from Hoechst to SHIPL by way of an on-market block deal.

Corporate M&A, September 2026

TT&A advised Sanofi Healthcare India Private Limited (SHIPL) and Hoechst GmbH (Hoechst) in relation to an inter-se transfer of the equity share capital of Sanofi India Limited from Hoechst to SHIPL by way of an on-market block deal.

TT&A advised Sanofi Healthcare India Private Limited (SHIPL) and Hoechst GmbH (Hoechst) in relation to an inter-se transfer of 15.20% of the equity share capital of Sanofi India Limited from Hoechst to SHIPL by way of an on-market block deal.

TT&A Team: Kunal Thakore – Joint Managing Partner; Abhinav Kumar & Rebha Dakshini – Partners and Nandini Pradhan – Associate

Previous PostTT&A advised DBS Bank India Limited on a term loan facility availed by a leading listed REITNext PostECL Finance Limited v. Abhinav Mukherjee: Upending lender rights?

TT&A advised Sanofi Healthcare India Private Limited (SHIPL) and Hoechst GmbH (Hoechst) in relation to an inter-se transfer of the equity share capital of Sanofi India Limited from Hoechst to SHIPL by way of an on-market block deal.

Kunal Thakore

Abhinav Kumar

Rebha Dakshini

Practice Areas

Disclaimer